Stephen J. Blake

3.9k total citations · 1 hit paper
36 papers, 2.3k citations indexed

About

Stephen J. Blake is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Stephen J. Blake has authored 36 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 16 papers in Immunology and 6 papers in Molecular Biology. Recurrent topics in Stephen J. Blake's work include Cancer Immunotherapy and Biomarkers (13 papers), Immune Cell Function and Interaction (11 papers) and Immunotherapy and Immune Responses (9 papers). Stephen J. Blake is often cited by papers focused on Cancer Immunotherapy and Biomarkers (13 papers), Immune Cell Function and Interaction (11 papers) and Immunotherapy and Immune Responses (9 papers). Stephen J. Blake collaborates with scholars based in Australia, Japan and United States. Stephen J. Blake's co-authors include Michele W.L. Teng, Mark J. Smyth, Kazuyoshi Takeda, Jing Liu, Arabella Young, Shin Foong Ngiow, Stacey Allen, Michelle C.R. Yong, Heidi Harjunpää and A. Bruce Lyons and has published in prestigious journals such as Nature reviews. Immunology, PLoS ONE and Cancer Cell.

In The Last Decade

Stephen J. Blake

36 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic Disease

2016 569 citations Jing Liu, Stephen J. Blake et al. Cancer Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephen J. Blake Australia	20	1.3k	1.1k	513	348	202	36	2.3k
Melissa Damschroder United States	23	452 0.3×	666 0.6×	1.0k 2.0×	284 0.8×	190 0.9×	42	2.3k
Tahiro Shin United States	24	2.3k 1.7×	4.0k 3.7×	575 1.1×	218 0.6×	394 2.0×	26	5.1k
Marta Coscia Italy	27	884 0.7×	1.3k 1.2×	513 1.0×	100 0.3×	149 0.7×	80	2.2k
Alfredo Perales‐Puchalt United States	26	1.1k 0.8×	1.4k 1.3×	999 1.9×	287 0.8×	27 0.1×	71	2.9k
Junghwa Lee South Korea	15	1.0k 0.8×	1.3k 1.2×	340 0.7×	195 0.6×	29 0.1×	39	2.1k
Polina Stepensky Israel	28	500 0.4×	1.2k 1.1×	693 1.4×	160 0.5×	60 0.3×	134	2.5k
Saskia J. Santegoets Netherlands	31	1.9k 1.4×	2.3k 2.1×	720 1.4×	272 0.8×	19 0.1×	73	3.2k
Sasikanth Manne United States	22	1.8k 1.4×	2.2k 2.0×	952 1.9×	172 0.5×	26 0.1×	32	3.4k
Vijay K. Vanguri United States	18	1.3k 1.0×	1.7k 1.5×	362 0.7×	228 0.7×	18 0.1×	37	2.7k
Edward L. Hipkiss United States	13	1.9k 1.5×	2.6k 2.4×	395 0.8×	305 0.9×	24 0.1×	16	3.5k

Countries citing papers authored by Stephen J. Blake

Since Specialization

Citations

This map shows the geographic impact of Stephen J. Blake's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen J. Blake with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen J. Blake more than expected).

Fields of papers citing papers by Stephen J. Blake

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen J. Blake. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen J. Blake. The network helps show where Stephen J. Blake may publish in the future.

Co-authorship network of co-authors of Stephen J. Blake

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen J. Blake. A scholar is included among the top collaborators of Stephen J. Blake based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen J. Blake. Stephen J. Blake is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Teong, Xiao Tong, Lijun Zhao, Gary Wittert, et al.. (2025). Comparing the effectiveness of calorie restriction with and without time-restricted eating on the circadian regulation of metabolism: rationale and protocol of a three-arm randomised controlled trial in adults at risk of type 2 diabetes. Nutrition Research. 138. 33–44. 1 indexed citations

Geremew, Demeke, Lauren Sandeman, Stephen J. Blake, et al.. (2025). Development of a Novel Murine Model of In‐Stent Neoatherosclerosis. Journal of the American Heart Association. 14(22). e041260–e041260. 1 indexed citations

Thomas, E, Josephine A. Wright, Stephen J. Blake, et al.. (2023). Advancing translational research for colorectal immuno-oncology. British Journal of Cancer. 129(9). 1442–1450. 20 indexed citations

Blake, Stephen J., et al.. (2021). OX40‐targeted immune agonist antibodies induce potent antitumor immune responses without inducing liver damage in mice. FASEB BioAdvances. 3(10). 829–840. 2 indexed citations

Blake, Stephen J., Feargal J. Ryan, José A. Caparrós‐Martín, et al.. (2021). The immunotoxicity, but not anti-tumor efficacy, of anti-CD40 and anti-CD137 immunotherapies is dependent on the gut microbiota. Cell Reports Medicine. 2(12). 100464–100464. 26 indexed citations

Mittal, Deepak, Ailin Lepletier, Jason Madore, et al.. (2019). CD96 Is an Immune Checkpoint That Regulates CD8+ T-cell Antitumor Function. Cancer Immunology Research. 7(4). 559–571. 90 indexed citations

Harjunpää, Heidi, Stephen J. Blake, Elizabeth Ahern, et al.. (2018). Deficiency of host CD96 and PD-1 or TIGIT enhances tumor immunity without significantly compromising immune homeostasis. OncoImmunology. 7(7). e1445949–e1445949. 37 indexed citations

Arumugam, Sankar, Christian Rønn Hansen, Stephen J. Blake, et al.. (2018). Comparison of multi-institutional pre-treatment verification for VMAT of nasopharynx with delivery errors. Physica Medica. 53. 25–31. 8 indexed citations

Ngiow, Shin Foong, Arabella Young, Stephen J. Blake, et al.. (2016). Agonistic CD40 mAb-Driven IL12 Reverses Resistance to Anti-PD1 in a T-cell–Rich Tumor. Cancer Research. 76(21). 6266–6277. 72 indexed citations

10.

Liu, Jing, Stephen J. Blake, Heidi Harjunpää, et al.. (2016). Assessing Immune-Related Adverse Events of Efficacious Combination Immunotherapies in Preclinical Models of Cancer. Cancer Research. 76(18). 5288–5301. 76 indexed citations

11.

Blake, Stephen J., Kimberley Stannard, Jing Liu, et al.. (2016). Suppression of Metastases Using a New Lymphocyte Checkpoint Target for Cancer Immunotherapy. Cancer Discovery. 6(4). 446–459. 187 indexed citations

12.

Liu, Jing, Stephen J. Blake, Michelle C.R. Yong, et al.. (2016). Improved Efficacy of Neoadjuvant Compared to Adjuvant Immunotherapy to Eradicate Metastatic Disease. Cancer Discovery. 6(12). 1382–1399. 569 indexed citations breakdown →

13.

Souza-Fonseca-Guimarães, Fernando, Stephen J. Blake, Amani Makkouk, et al.. (2016). Anti-CD137 enhances anti-CD20 therapy of systemic B-cell lymphoma with altered immune homeostasis but negligible toxicity. OncoImmunology. 5(7). e1192740–e1192740. 10 indexed citations

14.

Blake, Stephen J. & Michele W.L. Teng. (2014). Role of IL-17 and IL-22 in autoimmunity and cancer. Actas Dermo-Sifiliográficas. 105. 41–50. 32 indexed citations

15.

Vial, Philip, Stephen J. Blake, Aimee L. McNamara, et al.. (2013). A new concept in detector design for radiation therapy: Simultaneous imaging and dosimetry for comprehensive treatment verification. 1–6. 3 indexed citations

16.

Blake, Stephen J., Timothy P. Hughes, & A. Bruce Lyons. (2012). Drug-interaction studies evaluating T-cell proliferation reveal distinct activity of dasatinib and imatinib in combination with cyclosporine A. Experimental Hematology. 40(8). 612–621.e6. 13 indexed citations

17.

Blake, Stephen J., et al.. (2012). RNA Interference for Viral Infections. Current Drug Targets. 13(11). 1411–1420. 16 indexed citations

18.

Fraser, Cara K., Stephen J. Blake, Kerrilyn R. Diener, et al.. (2008). Dasatinib inhibits recombinant viral antigen-specific murine CD4+ and CD8+ T-cell responses and NK-cell cytolytic activity in vitro and in vivo. Experimental Hematology. 37(2). 256–265. 50 indexed citations

19.

Blake, Stephen J., Timothy P. Hughes, Graham Mayrhofer, & A. Bruce Lyons. (2008). The Src/ABL kinase inhibitor dasatinib (BMS-354825) inhibits function of normal human T-lymphocytes in vitro. Clinical Immunology. 127(3). 330–339. 90 indexed citations

20.

Hide, Chris, Stephen J. Blake, Xiaolin Meng, et al.. (2005). An Investigation in the Use of GPS and INS Sensors for Structural Health Monitoring. Proceedings of the 18th International Technical Meeting of the Satellite Division of The Institute of Navigation (ION GNSS 2005). 2029–2038. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact